Sharma SK - Search Results

1

Metallothionein-mediated neuroprotection in genetically engineered mouse models of Parkinson's disease.

Ebadi M, Brown-Borg H, El Refaey H, Singh BB, Garrett S, Shavali S, Sharma SK. Ebadi M, et al. Among authors: sharma sk. Brain Res Mol Brain Res. 2005 Mar 24;134(1):67-75. doi: 10.1016/j.molbrainres.2004.09.011. Brain Res Mol Brain Res. 2005. PMID: 15790531 Free PMC article. Review.

2

Metallothionein attenuates 3-morpholinosydnonimine (SIN-1)-induced oxidative stress in dopaminergic neurons.

Sharma SK, Ebadi M. Sharma SK, et al. Antioxid Redox Signal. 2003 Jun;5(3):251-64. doi: 10.1089/152308603322110832. Antioxid Redox Signal. 2003. PMID: 12880480

3

Peroxynitrite and mitochondrial dysfunction in the pathogenesis of Parkinson's disease.

Ebadi M, Sharma SK. Ebadi M, et al. Among authors: sharma sk. Antioxid Redox Signal. 2003 Jun;5(3):319-35. doi: 10.1089/152308603322110896. Antioxid Redox Signal. 2003. PMID: 12880486 Review.

4

An improved method for analyzing coenzyme Q homologues and multiple detection of rare biological samples.

Sharma SK, Ebadi M. Sharma SK, et al. J Neurosci Methods. 2004 Aug 15;137(1):1-8. doi: 10.1016/j.jneumeth.2004.02.003. J Neurosci Methods. 2004. PMID: 15196822

5

Distribution kinetics of 18F-DOPA in weaver mutant mice.

Sharma SK, Ebadi M. Sharma SK, et al. Brain Res Mol Brain Res. 2005 Sep 13;139(1):23-30. doi: 10.1016/j.molbrainres.2005.05.018. Brain Res Mol Brain Res. 2005. PMID: 15979197

6

Peroxynitrite in the pathogenesis of Parkinson's disease and the neuroprotective role of metallothioneins.

Ebadi M, Sharma SK, Ghafourifar P, Brown-Borg H, El Refaey H. Ebadi M, et al. Among authors: sharma sk. Methods Enzymol. 2005;396:276-98. doi: 10.1016/S0076-6879(05)96024-2. Methods Enzymol. 2005. PMID: 16291239

7

Complex-1 activity and 18F-DOPA uptake in genetically engineered mouse model of Parkinson's disease and the neuroprotective role of coenzyme Q10.

Sharma SK, El Refaey H, Ebadi M. Sharma SK, et al. Brain Res Bull. 2006 Jun 15;70(1):22-32. doi: 10.1016/j.brainresbull.2005.11.019. Epub 2005 Dec 27. Brain Res Bull. 2006. PMID: 16750479

8

Metallothionein provides ubiquinone-mediated neuroprotection in Parkinson's disease.

Ebadi M, Sharma S, Muralikrishnan D, Shavali S, Eken J, Sangchot P, Chetsawang B, Brekke L. Ebadi M, et al. Proc West Pharmacol Soc. 2002;45:36-8. Proc West Pharmacol Soc. 2002. PMID: 12434520 Review. No abstract available.

9

Metallothioneins 1 and 2 attenuate peroxynitrite-induced oxidative stress in Parkinson disease.

Ebadi M, Sharma S. Ebadi M, et al. Exp Biol Med (Maywood). 2006 Oct;231(9):1576-83. doi: 10.1177/153537020623100919. Exp Biol Med (Maywood). 2006. PMID: 17018883

10

Coenzyme Q10 inhibits mitochondrial complex-1 down-regulation and nuclear factor-kappa B activation.

Ebadi M, Sharma SK, Wanpen S, Amornpan A. Ebadi M, et al. Among authors: sharma sk. J Cell Mol Med. 2004 Apr-Jun;8(2):213-22. doi: 10.1111/j.1582-4934.2004.tb00276.x. J Cell Mol Med. 2004. PMID: 15256069 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,402 results

Search Page

Filters